SOGROYA 15 mg/1.5 ml, solution for injection in a pre-filled pen pen
Active ingredients: Somapacitan
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionpensous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SOGROYA 15 mg/1,5 ml, solution injectable en stylo prérempli
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 stylo prérempli en verre multidose(s) de 1 cartouche(s) en verre
- Marketing authorisation holder
- NOVO NORDISK (DANEMARK)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 25 Aug 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Initial prescription by a specialist
- Renewal by a specialist only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62039227CIP73027801CIP133400930278017Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SOMAPACITANsolution | 15 mg · un stylo prérempli de 1,5 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.